Preview

Russian Journal of Gastroenterology, Hepatology, Coloproctology

Advanced search

Metabolic syndrome and pancreatic lesions

Abstract

Aim of investigation. To study features of pancreatic involvement in patients with metabolic syndrome

Material and methods. Overall 720 patients were investigated who have admitted to the clinic with referral diagnosis «chronic pancreatitis» (CP). Of them steatosis of pancreas (SP) was diagnosed in 49 and in 290 – chronic pancreatitis. Original investigation algorithm was based on tasks of the study and included careful inquiry and physical investigation of patients. Laboratory and instrumental studies included: total and biochemical blood tests, lipid profile, coprological test, transabdominal and (under specific indications) endoscopic abdominal US, esophagogastroduodenoscopy (EGDS), computer tomography (CT) of abdominal organs, magnetic-resonance investigation (MRI).

Results. According to diagnostic criteria of metabolic syndrome, the latter was detected in 48 patients. Abdominal CT was considered as non-invasive method of investigation allowing to reliably diagnose SP. At CT in 

49 cases SP was revealed. Direct CT signs of SP include decrease in pancreatic density score (<30 HU), lobulated pattern of the gland with pronounced fatty layers. Diagnosis of chronic pancreatitis was made according to conventional clinical, laboratory and radiological criteria. The metabolic syndrome was significantly more frequent (р<0,05) in patients with SP, than at chronic inflammatory pancreatitis: in 29 of 49 cases (59,2%) and in 29 of 147 cases (19,7%) respectively. The issue of application of new phospholipid drug Resalut in patients with SP, associated to hepatic steatosis and lipidemia is discussed.
Conclusion. Steatosis of the pancreas can be considered as diffuse development of fatty tissue in all parts of the organ, developing mainly on the background of metabolic syndrome and combined to smoldering pancreatic inflammation under influence of pancreatoxic factors – alcohol, gallstone disease. Efficacy of new phospholipid drug Resalut in patients with steatosis of the pancreas associated to hepatic steatosis and lipidemia is demonstrated.

About the Authors

O. S. Shifrin
State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian Federation
Russian Federation


I. A. Sokolina
State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian Federation
Russian Federation


A. E. Leonovich
State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian Federation
Russian Federation


M. A. Ashitko
State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian Federation
Russian Federation


T. L. Lemina
State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian Federation
Russian Federation


A. V. Korolyov
State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian Federation
Russian Federation


References

1. Гастроэнтерология: Национальное руководство / Под ред. В.Т. Ивашкина, Т.Л. Лапиной. – М.: ГэотарМедиа, 2008. – 700 с.

2. Дедов И.И., Мельниченко Г.А. Ожирение. – М.: Медицинское информационное агентство, 2004. – 449 с.

3. Минько Б.А., Пручанский В.С., Корытова Л.И. Комплексная лучевая диагностика заболеваний поджелудочной железы. – СПб: Гиппократ, 2001. – 136 с.

4. Bourliere M, Barthet M, Berthezene P, еt al. Is tobacco a risk factor for chronic pancreatitis and alcoholic cirrhosis? Gut. 1991; 32:1392–5.

5. Clowdhury P, Bone RC, Louria DB, Rayford PL. Effect of cigarette smoke on human serum inhibitory capacity and antitripsin concentration. Rev Respir Dis. 1982; 126:177–9.

6. Feigelson J. Pecau Y. Poquet M, еt al. Imaging changes in the pancreas in cystic fibrosis: a retrospective evaluation of 55 cases seen over a period of 9 years. J Pediatr Gastroenterol Nutr. 2000 Feb; 30 (2):145–51.

7. Fortson MR, Freedman SN, Webster BD. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol. 1995; 90:2134–9.

8. Kim KH. Kim CD. Ryu HS, еt al. Endoscopic retrograde pancreatographic findings of pancreatic lipomatosis. J Korean Med Sci. 1999 Oct; 14 (5): 578–81.

9. Klöppel G., Mailett B. Pathology of chronic pancreatitis // The Pancreas / Eds. Beger H.G., et al. – Oxford (London), 1998:720–3.

10. Levy P, Mathurin P, Rogueplo A, et al. A multidimensional case control study of dietary alcohol and tobacco habits in alcoholic men with chronic pancreatitis. Pancreas. 1995; 106:231–8.

11. Pitchumoni CS. Role of nutrition in chronic pancreatitis // Chronic Pancreatitis / Eds. Beger H, Buchler M, Ditschuneit H, Malfertheiner P. – Berlin, Heidelberg: Springer-Ferlag, 1990:15–25.


Review

For citations:


Shifrin O.S., Sokolina I.A., Leonovich A.E., Ashitko M.A., Lemina T.L., Korolyov A.V. Metabolic syndrome and pancreatic lesions. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2013;23(2):17-22. (In Russ.)

Views: 96


ISSN 1382-4376 (Print)
ISSN 2658-6673 (Online)